A population-based study of the diagnosis to treatment interval and overall survival for stage I non-small cell lung cancer treated with stereotactic body radiation therapy
The findings suggest that efforts to shorten DTI may improve patient survival in this population of patients with stage I non-adenocarcinoma NSCLC treated with SBRT in Ontario.